A comparative study of different methods for automatic identification of clopidogrel-induced bleeding in electronic health records

Size: px
Start display at page:

Download "A comparative study of different methods for automatic identification of clopidogrel-induced bleeding in electronic health records"

Transcription

1 A comparative study of different methods for automatic identification of clopidogrel-induced bleeding in electronic health records Hee-Jin Lee School of Biomedical Informatics The University of Texas Health Science Center at Houston

2 Introduction Pharmacogenomics The study of how genes affect a person s response to drugs Identifying common and rare genetic variants that contribute to drug efficacy and toxicity (e.g., adverse drug events, ADR) Identifying patients with specific ADR from EHR Costly and time consuming Automatic tools for ADR identification have been investigated. 2

3 Clopidogrel-induced bleeding Clopidogrel for coronary artery disease Often in association with aspirin (dual anti-platelet therapy, DAPT) Recommended by current guidelines Potentially life-threatening adverse bleeding by clopidogrel Genetically determined response Only 12% of the inter-individual variations are explained so far. On going study at Vanderbilt University Medical Center (VUMC) 3

4 Overview Automatic identification of clopidogrel-induced bleeding from EHR Use both structured and narrative data Comparative study of different features and classification methods EHR at VUMC Ini3al Screening Candidate Pa3ents Feature Extraction Features Automatic Classification Case Non-case 4

5 Data 2,268 candidate patients Patients who potentially had clopidogrel-induced bleeding Screening criterion: at least one bleeding ICD-9 code within the time period of clopidogrel mentions in a patient s medical record Manual classification into case or non-case 1,921 cases of clopidogrel-induced bleeding 347 non-cases Splitting into training/test set 1,521 patients for training 756 patients for test 5

6 Features Bleeding information Bleeding ICD-9 codes E.g , blood in stool (109 codes curated by experts) Bleeding CUIs as identified by KMCI (KnowledgeMap Concept Identifier) E.g. C , bleeding from larynx (465 CUIs curated by experts) Bleeding keywords E.g. epistaxis, melena (51 keywords curated by experts) Clopidogrel information Clopidogrel mention and signature (i.e., dosage, route, frequency, etc.) as identified by MedEx 6

7 Features Temporality between bleeding and clopidogrel Timestamps of bleeding, clopidogrel exposure, or other possible causes of bleeding (e.g., chest tube, stab wound ) Shortest time durations between clopidogrel exposure and bleeding, and between other possible causes of bleeding and bleeding Explicit evidence from physicians assertion E.g., Bleeding was substantial owing to the fact that the patient was on DAPT with aspirin and clopidogrel. Identified by simple rule: both clopidogrel and bleeding mention in a sentence without any negation 7

8 Classification methods Rule-based methods Temporality rule: case if there was bleeding after a mention of clopidogrel without any other possible bleeding causes in-between. Explicit evidence rule: case if there is an explicit evidence of clopidogrel-caused bleeding. Machine learning-based methods SVM classifier Bleeding, clopidogrel, temporality, and explicit evidence features and their combinations 8

9 Classification methods Scoring-based methods Use both temporality features and explicit evidence features. s = W duration (1 f duration /10, 000) +W explicit f explicit F duration S f duration f explicit W duration,w explicit score shortest 3me dura3on from clopidogrel exposure to bleeding existence of explicit evidence of clopidogrel-caused bleeding weights case if s cutoff, non-case otherwise. 9

10 Results Category System Description P R F + temporality rule Rule + explicit evidence rule union of temporality and explicit evidence rules bleeding and clopidogrel features ML + temporality feature explicit evidence feature temporality and explicit evidence features cutoff = Scoring cutoff = cutoff =

11 Results Explicit evidence feature shows the best precision. Combination of temporality feature and explicit evidence feature shows the best F-score. Overall, ML-based and scoring-based systems outperforms rule-based systems (F-score). When targeting 95% precision level, scoring system with cutoff 6 may be the best choice. 11

12 Error case Date: September 20th 2011 Recent episode of gross hematuria at OSH with resultant demand ischemia and NSTEMI. "Per Urology, no obvious source of hematuria and has not reoccured in house, will proceed with andcoaguadon and LHC. Please take plavix for three more days total. Bleeding in the past No bleeding as of Sep. 20th Taking clopidogrel as of Sep. 20th non-case, but identified as case by the systems Detailed analysis on temporality and drug status is required. 12

13 Summary Informatics approaches for identifying patients with clopidogrel-induced adverse bleeding. Useful features Temporality between clopidogrel and bleeding Textual evidence from physicians assertion Comparison of different classification methods ML and scoring methods are effective in terms of F-score. Scoring method can achieve a high precision with a reasonable recall. 13

14 Discussion The gold standard data set (candidate patients) was generated using ad-hoc rules. Different criteria for candidate case selection would result in different precision and recall. The generalizability of the findings from this study may need further validation. Application of the proposed methods to other ADR types would require additional manual work. 14

15 Acknowledgements University of Texas Health Science Center at Houston Min Jiang PhD Yonghui Wu PhD Hua Xu PhD Vanderbilt University School of Medicine Christian M. Shaffer MS John H. Cleator MD Eitan A. Friedman MD Dan M. Roden MD Josh Denny MD,MS University of Maryland School of Medicine Joshua P. Lewis MD 15

16 Thank you!!! Questions? 16

CLAMP-Cancer an NLP tool to facilitate cancer research using EHRs Hua Xu, PhD

CLAMP-Cancer an NLP tool to facilitate cancer research using EHRs Hua Xu, PhD CLAMP-Cancer an NLP tool to facilitate cancer research using EHRs Hua Xu, PhD School of Biomedical Informatics The University of Texas Health Science Center at Houston 1 Advancing Cancer Pharmacoepidemiology

More information

A long journey to short abbreviations: developing an open-source framework for clinical abbreviation recognition and disambiguation (CARD)

A long journey to short abbreviations: developing an open-source framework for clinical abbreviation recognition and disambiguation (CARD) Journal of the American Medical Informatics Association, 24(e1), 2017, e79 e86 doi: 10.1093/jamia/ocw109 Advance Access Publication Date: 18 August 2016 Research and Applications Research and Applications

More information

Building a framework for handling clinical abbreviations a long journey of understanding shortened words "

Building a framework for handling clinical abbreviations a long journey of understanding shortened words Building a framework for handling clinical abbreviations a long journey of understanding shortened words " Yonghui Wu 1 PhD, Joshua C. Denny 2 MD MS, S. Trent Rosenbloom 2 MD MPH, Randolph A. Miller 2

More information

325 mg aspirin and plavix

325 mg aspirin and plavix 325 mg aspirin and plavix 12-3-2006 Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been studied in a broad population of patients at high risk for. Compare Aspirin

More information

Implementation of Pharmacogenomics in Clinical Medicine in the USA

Implementation of Pharmacogenomics in Clinical Medicine in the USA Implementation of Pharmacogenomics in Clinical Medicine in the USA Dan M. Roden, MD Senior Vice President for Personalized Medicine Vanderbilt University Medical Center, Nashville, TN The vision "Here's

More information

Plavix duration of effect

Plavix duration of effect Plavix duration of effect The Borg System is 100 % Plavix duration of effect Jan 20, 2015. If you have had stent placement after balloon angioplasty for coronary artery disease you will be placed on medications

More information

JOINT MEETING OF CORONARY REVASCULARIZATION 2014 TIONG LEE LEN SENIOR RESEARCH PHARMACIST CLINICAL RESEARCH CENTER, SARAWAK GENERAL HOSPITAL

JOINT MEETING OF CORONARY REVASCULARIZATION 2014 TIONG LEE LEN SENIOR RESEARCH PHARMACIST CLINICAL RESEARCH CENTER, SARAWAK GENERAL HOSPITAL The Effect of Non Steady State and Steady State Clopidogrel Carboxylic Acid Plasma Concentration on Clopidogrel Responsiveness in Patients Planned For Percutaneous Coronary Intervention JOINT MEETING OF

More information

Text mining for lung cancer cases over large patient admission data. David Martinez, Lawrence Cavedon, Zaf Alam, Christopher Bain, Karin Verspoor

Text mining for lung cancer cases over large patient admission data. David Martinez, Lawrence Cavedon, Zaf Alam, Christopher Bain, Karin Verspoor Text mining for lung cancer cases over large patient admission data David Martinez, Lawrence Cavedon, Zaf Alam, Christopher Bain, Karin Verspoor Opportunities for Biomedical Informatics Increasing roll-out

More information

A Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U

A Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U A Predictive Chronological Model of Multiple Clinical Observations T R A V I S G O O D W I N A N D S A N D A M. H A R A B A G I U T H E U N I V E R S I T Y O F T E X A S A T D A L L A S H U M A N L A N

More information

COMPARISON OF BREAST CANCER STAGING IN NATURAL LANGUAGE TEXT AND SNOMED ANNOTATED TEXT

COMPARISON OF BREAST CANCER STAGING IN NATURAL LANGUAGE TEXT AND SNOMED ANNOTATED TEXT Volume 116 No. 21 2017, 243-249 ISSN: 1311-8080 (printed version); ISSN: 1314-3395 (on-line version) url: http://www.ijpam.eu ijpam.eu COMPARISON OF BREAST CANCER STAGING IN NATURAL LANGUAGE TEXT AND SNOMED

More information

Pharmacogenomics with Clopidogrel: Does One Size Fit All?

Pharmacogenomics with Clopidogrel: Does One Size Fit All? Pharmacogenomics with Clopidogrel: Does One Size Fit All? Leah A. Sabato, PharmD PGY-1 Pharmacy Practice Resident UC Health - University of Cincinnati Medical Center leah.sabato@uchealth.com April 2015

More information

Clinical Event Detection with Hybrid Neural Architecture

Clinical Event Detection with Hybrid Neural Architecture Clinical Event Detection with Hybrid Neural Architecture Adyasha Maharana Biomedical and Health Informatics University of Washington, Seattle adyasha@uw.edu Meliha Yetisgen Biomedical and Health Informatics

More information

When and how to combine antiplatelet agents and anticoagulant?

When and how to combine antiplatelet agents and anticoagulant? When and how to combine antiplatelet agents and anticoagulant? Christophe Beauloye, MD, PhD Head, Division of Cardiology Cliniques Universitaires Saint-Luc Brussels, Belgium Introduction Anticoagulation

More information

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals.

OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME. TARGET AUDIENCE: All Canadian health care professionals. OUTPATIENT ANTITHROMBOTIC MANAGEMENT POST NON-ST ELEVATION ACUTE CORONARY SYNDROME TARGET AUDIENCE: All Canadian health care professionals. OBJECTIVE: To review the use of antiplatelet agents and oral

More information

Chapter 12 Conclusions and Outlook

Chapter 12 Conclusions and Outlook Chapter 12 Conclusions and Outlook In this book research in clinical text mining from the early days in 1970 up to now (2017) has been compiled. This book provided information on paper based patient record

More information

A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1

A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1 A Study of Abbreviations in Clinical Notes Hua Xu MS, MA 1, Peter D. Stetson, MD, MA 1, 2, Carol Friedman Ph.D. 1 1 Department of Biomedical Informatics, Columbia University, New York, NY, USA 2 Department

More information

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None

8/28/2018. Pre-op Evaluation for non cardiac surgery. A quick review from 2007!! Disclosures. John Steuter, MD. None Pre-op Evaluation for non cardiac surgery John Steuter, MD Disclosures None A quick review from 2007!! Fliesheret al, ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and are for Noncardiac

More information

Eliquis and plavix combination therapy

Eliquis and plavix combination therapy Eliquis and plavix combination therapy ELIQUIS Dosing for Patients With NVAF. patients treated with aspirin or the combination of bleeding or completion of a course of therapy,. 9-11-2011 Thrombosis is

More information

Natural Language Processing for EHR-Based Computational Phenotyping

Natural Language Processing for EHR-Based Computational Phenotyping IEEE TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (ACCEPTED) 1 Natural Language Processing for EHR-Based Computational Phenotyping Zexian Zeng, Yu Deng, Xiaoyu Li, Tristan Naumann, Yuan Luo

More information

Retrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish

Retrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish Retrieving disorders and findings: Results using SNOMED CT and NegEx adapted for Swedish Maria Skeppstedt 1,HerculesDalianis 1,andGunnarHNilsson 2 1 Department of Computer and Systems Sciences (DSV)/Stockholm

More information

Supplementary Online Content

Supplementary Online Content Supplementary Online Content Guimarães PO, Krishnamoorthy A, Kaltenbach LA, et al. Accuracy of medical claims for identifying cardiovascular and bleeding events after myocardial infarction: a secondary

More information

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1)

Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Low Dose Rivaroxaban Versus Aspirin, in Addition to P2Y12 Inhibition, in Acute Coronary Syndromes (GEMINI-ACS-1) Caitlin C. Akerman, PharmD PGY2 Cardiology Resident WakeMed Health & Hospitals Raleigh,

More information

Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center

Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center Prasugrel vs. Ticagrelor in ACS/PCI Which one to choose? V. Voudris MD FESC FACC 2 nd Cardiology Division Onassis Cardiac Surgery Center Hospitalizations in the U.S. Due to ACS Acute Coronary Syndromes

More information

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017

Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

Author: K. Ketchum Date: July 2015

Author: K. Ketchum Date: July 2015 Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment Prepared and Presented by Jon Manocchio, Pharm D Blanchard Valley Hospital October 2011 Introduction PAD is a condition that is

More information

Antiplatelet and Anti-Thrombotic Therapy. Ivan Anderson, MD RIHVH Cardiology

Antiplatelet and Anti-Thrombotic Therapy. Ivan Anderson, MD RIHVH Cardiology Antiplatelet and Anti-Thrombotic Therapy Ivan Anderson, MD RIHVH Cardiology Outline Anti-thrombotic therapy Risk stratification of stroke with atrial fibrillation DVT and PE treatment Pharmacology Anti-platelet

More information

FDA Workshop NLP to Extract Information from Clinical Text

FDA Workshop NLP to Extract Information from Clinical Text FDA Workshop NLP to Extract Information from Clinical Text Murthy Devarakonda, Ph.D. Distinguished Research Staff Member PI for Watson Patient Records Analytics Project IBM Research mdev@us.ibm.com *This

More information

A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions

A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions Drug Saf (2015) 38:895 908 DOI 10.1007/s40264-015-0314-8 ORIGINAL RESEARCH ARTICLE A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug

More information

HHS Public Access Author manuscript Stud Health Technol Inform. Author manuscript; available in PMC 2016 July 22.

HHS Public Access Author manuscript Stud Health Technol Inform. Author manuscript; available in PMC 2016 July 22. Analyzing Differences between Chinese and English Clinical Text: A Cross-Institution Comparison of Discharge Summaries in Two Languages Yonghui Wu a,*, Jianbo Lei a,b,*, Wei-Qi Wei c, Buzhou Tang a, Joshua

More information

Yes No Unknown. Major Infection Information

Yes No Unknown. Major Infection Information Rehospitalization Intervention Check any that occurred during this hospitalization. Pacemaker without ICD ICD Atrial arrhythmia ablation Ventricular arrhythmia ablation Cardioversion CABG (coronary artery

More information

Extracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov

Extracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov Extracting genetic alteration information for personalized cancer therapy from ClinicalTrials.gov RECEIVED 15 September 2015 REVISED 7 December 2015 ACCEPTED 13 January 2016 PUBLISHED ONLINE FIRST 24 March

More information

SUPRA PUBIC CATHETER(SPC)

SUPRA PUBIC CATHETER(SPC) Suprapubic versus urethral catheter? When a long-term catheter to drain the bladder is advised, it can be placed in the urethra (water pipe) or suprapubically (directly into the bladder through the skin

More information

Laparoscopic Radical Removal of the Kidney +/- Ureter

Laparoscopic Radical Removal of the Kidney +/- Ureter Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward

More information

FIXATION OF A RETRACTILE TESTIS

FIXATION OF A RETRACTILE TESTIS Procedure Specific Information What is the evidence base for this information? This publication includes advice from consensus panels, the British Association of Urological Surgeons, the Department of

More information

Preoperative Management of Patients Receiving Antithrombotics

Preoperative Management of Patients Receiving Antithrombotics Preoperative Management of Patients Receiving Antithrombotics Bleeding complications remain an important concern for most surgical procedures. Attempts to minimize the risk of these complications by removing

More information

IBM Research Report. Automated Problem List Generation from Electronic Medical Records in IBM Watson

IBM Research Report. Automated Problem List Generation from Electronic Medical Records in IBM Watson RC25496 (WAT1409-068) September 24, 2014 Computer Science IBM Research Report Automated Problem List Generation from Electronic Medical Records in IBM Watson Murthy Devarakonda, Ching-Huei Tsou IBM Research

More information

Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains

Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains Knowledge networks of biological and medical data An exhaustive and flexible solution to model life sciences domains Dr. Sascha Losko, Dr. Karsten Wenger, Dr. Wenzel Kalus, Dr. Andrea Ramge, Dr. Jens Wiehler,

More information

CrackCast Episode 30 GI Bleeding

CrackCast Episode 30 GI Bleeding CrackCast Episode 30 GI Bleeding Episode overview: 1) List 5 causes of UGIB in adults and pediatrics 2) List 5 causes of LGIB in adults and pediatrics 3) Describe your management approach for severe UGIB

More information

What is precision medicine and how has it evolved over time? Sara Van Driest, MD, PhD Vanderbilt University Medical Center March 2, 2016

What is precision medicine and how has it evolved over time? Sara Van Driest, MD, PhD Vanderbilt University Medical Center March 2, 2016 What is precision medicine and how has it evolved over time? Sara Van Driest, MD, PhD Vanderbilt University Medical Center March 2, 2016 What is Precision Medicine Precision medicine is an emerging approach

More information

Factuality Levels of Diagnoses in Swedish Clinical Text

Factuality Levels of Diagnoses in Swedish Clinical Text User Centred Networked Health Care A. Moen et al. (Eds.) IOS Press, 2011 2011 European Federation for Medical Informatics. All rights reserved. doi:10.3233/978-1-60750-806-9-559 559 Factuality Levels of

More information

Asthma Surveillance Using Social Media Data

Asthma Surveillance Using Social Media Data Asthma Surveillance Using Social Media Data Wenli Zhang 1, Sudha Ram 1, Mark Burkart 2, Max Williams 2, and Yolande Pengetnze 2 University of Arizona 1, PCCI-Parkland Center for Clinical Innovation 2 {wenlizhang,

More information

Timing of Surgery After Percutaneous Coronary Intervention

Timing of Surgery After Percutaneous Coronary Intervention Timing of Surgery After Percutaneous Coronary Intervention Deepak Talreja, MD, FACC Bayview/EVMS/Sentara Outline/Highlights Timing of elective surgery What to do with medications Stopping anti-platelet

More information

A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS

A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS A Randomized Trial Evaluating Clinically Significant Bleeding with Low-Dose Rivaroxaban vs Aspirin, in Addition to P2Y12 inhibition, in ACS Magnus Ohman MB, on behalf of the GEMINI-ACS-1 Investigators

More information

Joint Meeting of Coronary Revascularization 8 th to 9 th December 2017

Joint Meeting of Coronary Revascularization 8 th to 9 th December 2017 B Joint Meeting of Coronary Revascularization 8 th to 9 th December 2017 A Novel Clinical Application Combining Genotyping and Platetlet Function Testing In Patients With Acs - A Case Series Shirley Tan

More information

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24.

3/23/2017. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate Europace Oct;14(10): Epub 2012 Aug 24. Angelika Cyganska, PharmD Austin T. Wilson, MS, PharmD Candidate 2017 Explain the efficacy and safety of triple therapy, in regards to thromboembolic and bleeding risk Summarize the guideline recommendations

More information

On-time clinical phenotype prediction based on narrative reports

On-time clinical phenotype prediction based on narrative reports On-time clinical phenotype prediction based on narrative reports Cosmin A. Bejan, PhD 1, Lucy Vanderwende, PhD 2,1, Heather L. Evans, MD, MS 3, Mark M. Wurfel, MD, PhD 4, Meliha Yetisgen-Yildiz, PhD 1,5

More information

Comparing ICD9-Encoded Diagnoses and NLP-Processed Discharge Summaries for Clinical Trials Pre-Screening: A Case Study

Comparing ICD9-Encoded Diagnoses and NLP-Processed Discharge Summaries for Clinical Trials Pre-Screening: A Case Study Comparing ICD9-Encoded Diagnoses and NLP-Processed Discharge Summaries for Clinical Trials Pre-Screening: A Case Study Li Li, MS, Herbert S. Chase, MD, Chintan O. Patel, MS Carol Friedman, PhD, Chunhua

More information

Authors: Shuling Li, PhD 1, Julia Molony, MS 1, Karynsa Cetin, MPH 2, Jeffrey Wasser, MD 3, Ivy Altomare, MD 4

Authors: Shuling Li, PhD 1, Julia Molony, MS 1, Karynsa Cetin, MPH 2, Jeffrey Wasser, MD 3, Ivy Altomare, MD 4 Rate of Bleeding-Related Episodes (BREs) in Elderly Patients with Primary Immune Thrombocytopenia (ITP): A Population-Based Retrospective Cohort Study Using Medicare 20% Sample Data Authors: Shuling Li,

More information

Partial Removal of the Kidney

Partial Removal of the Kidney Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact Ward 4A, 4B or

More information

UW MEDICINE PATIENT EDUCATION. Treatment for blocked heart arteries DRAFT. What are arteries? How do heart arteries become blocked?

UW MEDICINE PATIENT EDUCATION. Treatment for blocked heart arteries DRAFT. What are arteries? How do heart arteries become blocked? UW MEDICINE PATIENT EDUCATION Complex Percutaneous Coronary Intervention (PCI) Treatment for blocked heart arteries This handout explains complex percutaneous intervention (PCI) treatment of a coronary

More information

Open Radical Removal of the Kidney

Open Radical Removal of the Kidney Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward

More information

Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials

Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials Case-based reasoning using electronic health records efficiently identifies eligible patients for clinical trials Riccardo Miotto and Chunhua Weng Department of Biomedical Informatics Columbia University,

More information

Extracting geographic locations from the literature for virus phylogeography using supervised and distant supervision methods

Extracting geographic locations from the literature for virus phylogeography using supervised and distant supervision methods Extracting geographic locations from the literature for virus phylogeography using supervised and distant supervision methods D. Weissenbacher 1, A. Sarker 2, T. Tahsin 1, G. Gonzalez 2 and M. Scotch 1

More information

The Dual Antiplatelet Therapy (DAPT) Trial: An FDA Perspective

The Dual Antiplatelet Therapy (DAPT) Trial: An FDA Perspective The Dual Antiplatelet Therapy (DAPT) Trial: An FDA Perspective Bram Zuckerman, MD, FACC Director, FDA Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

TeamHCMUS: Analysis of Clinical Text

TeamHCMUS: Analysis of Clinical Text TeamHCMUS: Analysis of Clinical Text Nghia Huynh Faculty of Information Technology University of Science, Ho Chi Minh City, Vietnam huynhnghiavn@gmail.com Quoc Ho Faculty of Information Technology University

More information

Chapter 2. The Research Process: Coming to Terms Pearson Prentice Hall, Salkind. 1

Chapter 2. The Research Process: Coming to Terms Pearson Prentice Hall, Salkind. 1 Chapter 2 The Research Process: Coming to Terms 2009 Pearson Prentice Hall, Salkind. 1 CHAPTER OBJECTIVES - STUDENTS SHOULD BE ABLE TO: Describe the research process from formulating questions to seeking

More information

Uroradiology For Medical Students

Uroradiology For Medical Students Uroradiology For Medical Students Lesson 8 Computerized Tomography 2 American Urological Association Objectives In this lesson you will: Gain more experience reading CT images Learn how computer generated

More information

Truth Versus Truthiness in Clinical Data

Truth Versus Truthiness in Clinical Data Temple University Health System Truth Versus Truthiness in Clinical Data Mark Weiner, MD, FACP, FACMI Assistant Dean for Informatics, Temple University School of Medicine mark.weiner@tuhs.temple.edu 1

More information

Health Informa.cs. Lecture 9. Samantha Kleinberg

Health Informa.cs. Lecture 9. Samantha Kleinberg Health Informa.cs Lecture 9 Samantha Kleinberg samantha.kleinberg@stevens.edu Next week: journal club For all papers: read, and prepare to comment on For your paper: Read the ar.cle (+ other references

More information

Doncaster & Bassetlaw Medicines Formulary

Doncaster & Bassetlaw Medicines Formulary Doncaster & Bassetlaw Medicines Formulary Section 2.9: Antiplatelet Drugs Aspirin 75mg Dispersible Tablets Aspirin 300mg Dispersible Tablets Aspirin 300mg Suppositories Clopidogrel 75mg Tablets Dipyridamole

More information

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures)

More information

Bleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM

Bleeding Management Strategies. Aiming for the best Outcomes August 27, Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM Bleeding Management Strategies Aiming for the best Outcomes August 27, 2016 Amit Gupta, MD FACC FSCAI Interventional Cardiologist CANM Learning Objectives Review the use of anti-coagulants in patients

More information

Optimal Duration of Dual Anti- Platelet Therapy. December 19, 2015

Optimal Duration of Dual Anti- Platelet Therapy. December 19, 2015 Optimal Duration of Dual Anti- Platelet Therapy December 19, 2015 John S. MacGregor, M.D., Ph.D. Professor of Medicine University of California San Francisco Source: The New Yorker 1 Optimal Duration of

More information

Thrombosis Research active studies

Thrombosis Research active studies Thrombosis Research active studies A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients With Coronary Artery Disease Undergoing PCI With CYP2C19 Loss-of-function Genotypes: A Feasibility

More information

- May Help Increase Appropriate Early Use in Acute Coronary Syndrome Patients -

- May Help Increase Appropriate Early Use in Acute Coronary Syndrome Patients - MEDIA INVESTORS Ken Dominski John Elicker Bristol-Myers Squibb Bristol-Myers Squibb 609-252-5251 212-546-3775 ken.dominski@bms.com john.elicker@bms.com Amy Ba Felix Lauscher sanofi-aventis sanofi-aventis

More information

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010

The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 21 July 2010 The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 21 July 2010 DUOPLAVIN 75 mg/75 mg, film-coated tablet B/30 (CIP code: 359 022-6) B/30 (CIP code: 382 063-7) DUOPLAVIN

More information

Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events

Head-to-Head Study Showed Prasugrel Statistically Superior to Clopidogrel in Reducing Recurrent Cardiovascular Events Date: August 21, 2008 Refer to: Carole Copeland (OUS) Eli Lilly and Company 317-277-3661 (office) 317-610-6196 (cell) Tammy Hull (U.S.A.) Eli Lilly and Company 317-651-9116 (office) 317-614-5132 (cell)

More information

SACRAL NERVE STIMULATION (NEUROMODULATION)

SACRAL NERVE STIMULATION (NEUROMODULATION) SACRAL NERVE STIMULATION (NEUROMODULATION) What evidence is this information based on? This leaflet includes advice from consensus panels, ICI and ICS. You should read this leaflet with any advice your

More information

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.

Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease. Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν. Antiplatelet Therapy in Primary CVD Prevention and Stable Coronary Artery Disease Καρακώστας Γεώργιος Διευθυντής Καρδιολογικής Κλινικής, Γ.Ν.Κιλκίς Primary CVD Prevention A co-ordinated set of actions,

More information

LAPAROSCOPIC RADICAL REMOVAL OF THE KIDNEY INFORMATION FOR PATIENTS

LAPAROSCOPIC RADICAL REMOVAL OF THE KIDNEY INFORMATION FOR PATIENTS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk LAPAROSCOPIC

More information

Laparoscopic partial removal of the kidney

Laparoscopic partial removal of the kidney Laparoscopic partial removal of the kidney Department of Urology 2 Patient Information What evidence is this information based on? This booklet includes advice from consensus panels, the British Association

More information

2.5 Other Hematology Consult:

2.5 Other Hematology Consult: The Warfarin Order Sheet has been approved by the P & T committee to be implemented by pharmacists. These orders are not used to treat patients with serious hemorrhagic complications. WARFARIN TARGET INR

More information

Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes

Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes Surveillance of Peripheral Arterial Disease Cases Using Natural Language Processing of Clinical Notes Naveed Afzal, Sunghwan Sohn, Christopher G. Scott, Hongfang Liu, Iftikhar J. Kullo, Adelaide M. Arruda-Olson

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1

More information

Dual Antiplatelet Therapy Made Practical

Dual Antiplatelet Therapy Made Practical Dual Antiplatelet Therapy Made Practical David Parra, Pharm.D., FCCP, BCPS Clinical Pharmacy Program Manager in Cardiology/Anticoagulation VISN 8 Pharmacy Benefits Management Clinical Associate Professor

More information

Diagnostic laparoscopy: procedure-specific information

Diagnostic laparoscopy: procedure-specific information PATIENT INFORMATION Diagnostic laparoscopy: procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels, the British Association of

More information

INFORMATION FOR PATIENTS

INFORMATION FOR PATIENTS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E- mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk INFORMATION

More information

Simple removal of the kidney (simple nephrectomy): procedure-specific information

Simple removal of the kidney (simple nephrectomy): procedure-specific information PATIENT INFORMATION Simple removal of the kidney (simple nephrectomy): procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels,

More information

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI

The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI The Future of Oral Antiplatelets in PAD and CAD Christopher Paris, MD, FACC, FSCAI Interventional Cardiologist Cardiovascular Institute of the South Director of Cardiovascular Services St. Charles Parish

More information

Update on Antiplatelet Therapy

Update on Antiplatelet Therapy Update on Antiplatelet Therapy Christine Ibarra Pharm.D. PGY-1 Baptist Hospital of Miami Objectives Explain the role of antiplatelettherapy in prevention of cardiovascular events Appreciate differences

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

Learning Objectives. Epidemiology of Acute Coronary Syndrome

Learning Objectives. Epidemiology of Acute Coronary Syndrome Cardiovascular Update: Antiplatelet therapy in acute coronary syndromes PHILLIP WEEKS, PHARM.D., BCPS-AQ CARDIOLOGY Learning Objectives Interpret guidelines as they relate to constructing an antiplatelet

More information

Περιφερική Αρτηριακή Νόσος Νόσος Καρωτίδων

Περιφερική Αρτηριακή Νόσος Νόσος Καρωτίδων Νεώτερα δεδομένα στην αντιαιμοπεταλιακή αγωγή που θα επηρεάσουν τις μελλοντικές κατευθυντήριες οδηγίες Περιφερική Αρτηριακή Νόσος Νόσος Καρωτίδων Μιλτιάδης Ματσάγκας, MD, PhD, FEBVS Αναπληρωτής Καθηγητής

More information

A Probabilistic Reasoning Method for Predicting the Progression of Clinical Findings from Electronic Medical Records

A Probabilistic Reasoning Method for Predicting the Progression of Clinical Findings from Electronic Medical Records A Probabilistic Reasoning Method for Predicting the Progression of Clinical Findings from Electronic Medical Records Travis Goodwin, Sanda M. Harabagiu, PhD University of Texas at Dallas, Richardson, TX,

More information

April 24, Seoul, South Korea

April 24, Seoul, South Korea Clinical Update of Resolute Integrity with DAPT Pooled RESOLUTE Clinical Program Josiah N. Wilcox, Ph.D. Chief Scientific Officer, Coronary and RDN Medtronic CardioVascular TCT-AP TCT AP April 24, 2013

More information

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology

STEMI update. Vijay Krishnamoorthy M.D. Interventional Cardiology STEMI update Vijay Krishnamoorthy M.D. Interventional Cardiology OVERVIEW Current Standard of Care in Management of STEMI Update in management of STEMI Pre-Cath Lab In the ED/Office/EMS. Cath Lab Post

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial

Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial Angina Anginal pain is a result of an imbalance between myocardial oxygen supply and demand. Pharmacological management is aimed at prevention of myocardial ischemia and pain as well as prevention of myocardial

More information

Cystoscopy & Evacuation of Blood Clots

Cystoscopy & Evacuation of Blood Clots Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward

More information

UTHealth at SemEval-2016 Task 12: an End-to-End System for Temporal Information Extraction from Clinical Notes

UTHealth at SemEval-2016 Task 12: an End-to-End System for Temporal Information Extraction from Clinical Notes UTHealth at SemEval-2016 Task 12: an End-to-End System for Temporal Information Extraction from Clinical Notes Hee-Jin Lee, Yaoyun Zhang, Jun Xu, Sungrim Moon, Jingqi Wang, Yonghui Wu, and Hua Xu University

More information

ACCP Cardiology PRN Journal Club

ACCP Cardiology PRN Journal Club ACCP Cardiology PRN Journal Club 1 Optimising Crossover from Ticagrelor to Clopidogrel in Patients with Acute Coronary Syndrome [CAPITAL OPTI-CROSS] Monique Conway, PharmD, BCPS PGY-2 Cardiology Pharmacy

More information

CYSTOSCOPY AND URETHRAL BULKING INJECTIONS INFORMATION FOR PATIENTS

CYSTOSCOPY AND URETHRAL BULKING INJECTIONS INFORMATION FOR PATIENTS The British Association of Urological Surgeons 35-43 Lincoln s Inn Fields London WC2A 3PE Phone: Fax: Website: E-mail: +44 (0)20 7869 6950 +44 (0)20 7404 5048 www.baus.org.uk admin@baus.org.uk CYSTOSCOPY

More information

Cystometrogram (Urodynamic Studies)

Cystometrogram (Urodynamic Studies) Who can I contact if I have a problem when I get home? If you experience any problems related to your surgery or admission once you have been discharged home. Please feel free to contact 4A, 4B or 4C ward

More information

Removal of Epididymal Cyst Urology Patient Information Leaflet

Removal of Epididymal Cyst Urology Patient Information Leaflet Removal of Epididymal Cyst Urology Patient Information Leaflet Page 1 What is an Epididymal Cyst? Epididymal cysts or as they are sometimes known spermatocele are cysts of the head of the epididymis that

More information

An unsupervised machine learning model for discovering latent infectious diseases using social media data

An unsupervised machine learning model for discovering latent infectious diseases using social media data Journal of Biomedical Informatics j o u r n al homepage: www.elsevier.com/locate/yj b i n An unsupervised machine learning model for discovering latent infectious diseases using social media data ARTICLE

More information

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά

Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής. Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά Διάρκεια διπλής αντιαιμοπεταλιακής αγωγής Νικόλαος Γ.Πατσουράκος Καρδιολόγος, Επιμελητής Α ΕΣΥ Τζάνειο Γενικό Νοσοκομείο Πειραιά International ACS guidelines: Recommendations on duration of dual

More information

A review of approaches to identifying patient phenotype cohorts using electronic health records

A review of approaches to identifying patient phenotype cohorts using electronic health records A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March

More information

Assessing the role of a medication-indication resource in the treatment relation extraction from clinical text

Assessing the role of a medication-indication resource in the treatment relation extraction from clinical text Assessing the role of a medication-indication resource in the treatment relation extraction from clinical text RECEIVED 5 May 2014 REVISED 16 September 2014 ACCEPTED 27 September 2014 PUBLISHED ONLINE

More information